dantrolene has been researched along with Hyperthermia in 5 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
Hyperthermia: An abnormal elevation of body temperature, usually as a result of inability to regulate core body temperature due to non-pathologic factors.
| Excerpt | Relevance | Reference |
|---|---|---|
| "On retrospective evaluation using the malignant hyperthermia scale, the present case was almost certainly that of a patient with MH." | 5.62 | Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report. ( Fukui, H; Ishida, Y; Kobayashi, T; Komiya, T; Miyazaki, N; Ogihara, Y; Okada, T; Uchino, H, 2021) |
| "Herein, the authors report a two-month-old infant who underwent holmium laser epiglottis retrofitting through a bronchoscope, but developed limb muscular stiffness, tachypnea, tachycardia, and hyperthermia after sevoflurane exposure." | 4.02 | The Use of Continuous Blood Purification for the Treatment of Malignant Hyperthermia in an Infant. ( Jing, Z; Li, Y; Sheng, C; Yang, C, 2021) |
| "Malignant hyperthermia (MH) is a severe hypermetabolic disorder associated with dysregulation of calcium homeostasis and is triggered by inhalational anesthetics (isoflurane, sevoflurane, desflurane) and a depolarizing muscle relaxant (succinylcholine)." | 4.02 | Malignant hyperthermia in a 16-day-old infant with congenital diaphragmatic hernia: a case report. ( Kakuta, N; Kanzaki, R; Kawanishi, R; Kondo, T; Miyoshi, H; Morio, A; Mukaida, K; Noda, Y; Tanaka, K; Tsutsumi, YM, 2021) |
| "On retrospective evaluation using the malignant hyperthermia scale, the present case was almost certainly that of a patient with MH." | 1.62 | Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report. ( Fukui, H; Ishida, Y; Kobayashi, T; Komiya, T; Miyazaki, N; Ogihara, Y; Okada, T; Uchino, H, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Min, JY | 1 |
| Hong, SH | 1 |
| Kim, SJ | 1 |
| Chung, MY | 1 |
| Bastian, B | 1 |
| Heiderich, S | 1 |
| Schuster, F | 1 |
| Johannsen, S | 1 |
| Klingler, W | 1 |
| Rüffert, H | 1 |
| Sheng, C | 1 |
| Yang, C | 1 |
| Jing, Z | 1 |
| Li, Y | 1 |
| Tsutsumi, YM | 1 |
| Kakuta, N | 1 |
| Kawanishi, R | 1 |
| Tanaka, K | 1 |
| Kanzaki, R | 1 |
| Morio, A | 1 |
| Noda, Y | 1 |
| Miyoshi, H | 1 |
| Kondo, T | 1 |
| Mukaida, K | 1 |
| Miyazaki, N | 1 |
| Kobayashi, T | 1 |
| Komiya, T | 1 |
| Okada, T | 1 |
| Ishida, Y | 1 |
| Fukui, H | 1 |
| Ogihara, Y | 1 |
| Uchino, H | 1 |
1 review available for dantrolene and Hyperthermia
| Article | Year |
|---|---|
[Comments on the guidelines of the European Malignant Hyperthermia Group on the availability of dantrolene for the management of malignant hyperthermia crises].
Topics: Dantrolene; Humans; Hyperthermia; Malignant Hyperthermia; Muscle Relaxants, Central | 2020 |
4 other studies available for dantrolene and Hyperthermia
| Article | Year |
|---|---|
Delayed-onset malignant hyperthermia in the postanesthetic care unit: a case report.
Topics: Aged; Anesthesia; Body Temperature; Dantrolene; Humans; Hyperthermia; Male; Malignant Hyperthermia | 2021 |
The Use of Continuous Blood Purification for the Treatment of Malignant Hyperthermia in an Infant.
Topics: Adult; Anesthesia, General; Child; Dantrolene; Humans; Hyperthermia; Infant; Male; Malignant Hyperth | 2021 |
Malignant hyperthermia in a 16-day-old infant with congenital diaphragmatic hernia: a case report.
Topics: Child; Dantrolene; Hernias, Diaphragmatic, Congenital; Humans; Hyperthermia; Infant; Malignant Hyper | 2021 |
Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
Topics: Anesthesia, General; Anesthetics, Inhalation; Breast Neoplasms; Calcium; Dantrolene; Female; Humans; | 2021 |